Y
Yaniv Sherer
Researcher at Ben-Gurion University of the Negev
Publications - 152
Citations - 8257
Yaniv Sherer is an academic researcher from Ben-Gurion University of the Negev. The author has contributed to research in topics: Antiphospholipid syndrome & Autoantibody. The author has an hindex of 48, co-authored 151 publications receiving 7831 citations. Previous affiliations of Yaniv Sherer include Barzilai Medical Center & Tel Aviv University.
Papers
More filters
Journal ArticleDOI
Autoantibody Explosion in Systemic Lupus Erythematosus: More Than 100 Different Antibodies Found in SLE Patients
TL;DR: SLE is the autoimmune disease with the largest number of detectable autoantibodies, and their production could be antigen-driven, the result of polyclonal B cell activation, impaired apoptotic pathways, or the outcome of idiotypic network dysregulation.
Journal ArticleDOI
Accelerated Atherosclerosis in Autoimmune Rheumatic Diseases
Yehuda Shoenfeld,Roberto Gerli,Andrea Doria,Eiji Matsuura,Marco Matucci Cerinic,Nicoletta Ronda,Luis J. Jara,Mahmud Abu-Shakra,Pier Luigi Meroni,Yaniv Sherer,Yaniv Sherer +10 more
TL;DR: Several AIRDs exhibit increased overt cardiovascular disease (CVD) prevalence as well as findings of advanced subclinical atherosclerosis, which may precede the appearance of a clinical disease and thus be a target of early identification and preventive therapy.
Journal ArticleDOI
Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus
Andrea Doria,Y Shoenfeld,R Wu,P. F. Gambari,Massimo Puato,Anna Ghirardello,Boris Gilburd,S. Corbanese,M. Patnaik,Sandra Zampieri,J. B. Peter,E Favaretto,L Iaccarino,Yaniv Sherer,Silvano Todesco,Paolo Pauletto +15 more
TL;DR: In patients with SLE some non-traditional risk factors for atherosclerosis were identified, the most important of which was the cumulative prednisone dose, and the role of some traditional risk factors, such as age and hypertension, was confirmed.
Journal ArticleDOI
Mechanisms of Disease: atherosclerosis in autoimmune diseases
TL;DR: The contribution of autoimmune elements, such as autoreactive lymphocytes and autoantibodies to Atherosclerosis and the nature of atherosclerosis in autoimmune rheumatic diseases are discussed.
Journal ArticleDOI
European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies
Marta Mosca,Chiara Tani,Martin Aringer,Stefano Bombardieri,Dimitrios T. Boumpas,Robin L. Brey,Ricard Cervera,Andrea Doria,David Jayne,Munther A. Khamashta,Annegret Kuhn,Caroline Gordon,Michelle Petri,Ole Petter Rekvig,Matthias Schneider,Yaniv Sherer,Yehuda Shoenfeld,Yehuda Shoenfeld,Josef S Smolen,Rosaria Talarico,Angela Tincani,R. van Vollenhoven,M. M. Ward,Victoria P. Werth,Loreto Carmona +24 more
TL;DR: A ‘core set’ of minimal variables for the assessment and monitoring of patients with SLE in clinical practice was developed that included some of the recommendations and indications for specific organ assessments that were viewed as part of good clinical practice.